Cargando…

Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease

AIMS: In the present study, we investigated whether apolipoprotein E (APOE) polymorphisms influenced the cognitive function of Japanese patients with Alzheimer's disease (AD) at certain ages. METHODS: Among 200 outpatients with dementia and amnestic mild cognitive impairment, 133 Japanese patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagata, Tomoyuki, Shinagawa, Shunichiro, Kuerban, Bolati, Shibata, Nobuto, Ohnuma, Tohru, Arai, Heii, Nakayama, Kazuhiko, Yamada, Hisashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2013
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618110/ https://www.ncbi.nlm.nih.gov/pubmed/23569459 http://dx.doi.org/10.1159/000348351

Ejemplares similares

Genetic Association between Neurotrophin-3 Polymorphisms and Alzheimer's Disease in Japanese Patients
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2015)

Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population
por: Shibata, Nobuto, et al.
Publicado: (2011)

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
por: Suzuki, Ayako, et al.
Publicado: (2016)

Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia
por: Shibata, Nobuto, et al.
Publicado: (2013)

No Associations Found between PGBD1 and the Age of Onset in Japanese Patients Diagnosed with Sporadic Alzheimer's Disease
por: Ohnuma, Tohru, et al.
Publicado: (2012)

Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study
por: Ohnuma, Tohru, et al.
Publicado: (2016)

Genetic or Psychogenic? A Case Study of “Folie à Quatre” Including Twins
por: Ohnuma, Tohru, et al.
Publicado: (2015)

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2022)

Supplementation with Matured Hop Bitter Acids Improves Cognitive Performance and Mood State in Healthy Older Adults with Subjective Cognitive Decline
por: Fukuda, Takafumi, et al.
Publicado: (2020)

Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months
por: Regal, Paul, et al.
Publicado: (2013)

Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia
por: Ohnuma, Tohru, et al.
Publicado: (2018)

Apolipoprotein E ε-4 as a genetic determinant of Alzheimer’s disease heterogeneity
por: Kotze, MJ, et al.
Publicado: (2015)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
por: Suzuki, Kazushi, et al.
Publicado: (2020)

Overlap Between Apolipoprotein Eε4 Allele and Slowing Gait Results in Cognitive Impairment
por: Sakurai, Ryota, et al.
Publicado: (2019)

Ginseng intake and Alzheimer disease-specific cognition in older adults according to apolipoprotein ε4 allele status
por: Lee, Boung Chul, et al.
Publicado: (2023)

Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases
por: Abyadeh, Morteza, et al.
Publicado: (2023)

Apolipoprotein E ε4 allele and malondialdehyde level are independent risk factors for Alzheimer’s disease
por: López-Riquelme, Natividad, et al.
Publicado: (2016)

Sex differences in the association between apolipoprotein E ε4 allele and Alzheimer's disease markers
por: Sundermann, Erin E., et al.
Publicado: (2018)

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
por: Kobayashi, Nobuyuki, et al.
Publicado: (2022)

A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom
por: Nagata, Tomoyuki, et al.
Publicado: (2021)

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
por: Kobayashi, Nobuyuki, et al.
Publicado: (2020)

Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status
por: Xing, Yi, et al.
Publicado: (2015)

Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
por: Pocevičiūtė, Dovilė, et al.
Publicado: (2022)

Meta-analysis for the Association of Apolipoprotein E ε2/ε3/ε4 Polymorphism with Coronary Heart Disease
por: Zhang, Yong, et al.
Publicado: (2015)

Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan
por: Kobayashi, Hiroyuki, et al.
Publicado: (2018)

A Meta-Analysis of Apolipoprotein E Gene ε2/ε3/ε4 Polymorphism for Gallbladder Stone Disease
por: Xue, Pei, et al.
Publicado: (2012)

Effect of Apolipoprotein E ε4 Allele on the Progression of Carotid Atherosclerosis Through Apolipoprotein Levels
por: Ma, Wenbing, et al.
Publicado: (2022)

Behavioral and cognitive performance of humanized APOEε3/ε3 liver mice in relation to plasma apolipoprotein E levels
por: Kessler, Kat, et al.
Publicado: (2023)

Longitudinal Changes in the Government-Certified Index Stage and Requisite Costs for Long-Term Care Insurance System among the Community-Dwelling Demented Elderly in Japan
por: Shinagawa, Shunichiro, et al.
Publicado: (2013)

Genetic influence of Apolipoprotein E gene ε2/ε3/ε4 isoforms on odds of mesial temporal lobe epilepsy
por: Xu, Tao, et al.
Publicado: (2021)

Apolipoprotein-E (Apoe) ε4 and cognitive decline over the adult life course
por: Rawle, Mark James, et al.
Publicado: (2018)

Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein ε4 allele
por: Remer, Justin, et al.
Publicado: (2020)

A genetic signature including apolipoprotein Eε4 potentiates the risk of herpes simplex–associated Alzheimer's disease
por: Lopatko Lindman, Karin, et al.
Publicado: (2019)

A Case of Cerebral Amyloid Angiopathy-Related Inflammation With the Rare Apolipoprotein ε2/ε2 Genotype
por: Xu, Yin-Yan, et al.
Publicado: (2019)

High Glycemic Load Is Associated with Cognitive Decline in Apolipoprotein E ε4 Allele Carriers
por: Gentreau, Mélissa, et al.
Publicado: (2020)

Apolipoprotein ε4 modifies obesity-related atrophy in the hippocampal formation of cognitively healthy adults
por: Coad, Bethany M., et al.
Publicado: (2022)

Similar promotion of Aβ(1-42 )fibrillogenesis by native apolipoprotein E ε3 and ε4 isoforms
por: Sweeney, David, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_evk0masjgrjjm54dc0hmc2p0p3